These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6434846)

  • 1. Animal models for dicarboxylic aciduria.
    Sherratt HS; Veitch RK
    J Inherit Metab Dis; 1984; 7 Suppl 1():52-6. PubMed ID: 6434846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study.
    Van Hoof F; Hue L; Vamecq J; Sherratt HS
    Biochem J; 1985 Jul; 229(2):387-97. PubMed ID: 4038275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
    Turnbull DM; Bartlett K; Younan SI; Sherratt HS
    Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.
    Rhead WJ; Amendt BA; Fritchman KS; Felts SJ
    Science; 1983 Jul; 221(4605):73-5. PubMed ID: 6857268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates.
    Sherratt HS
    Biochem Soc Trans; 1985 Oct; 13(5):856-8. PubMed ID: 2866127
    [No Abstract]   [Full Text] [Related]  

  • 6. Organic aciduria in rats made resistant to hypoglycin toxicity by pretreatment with clofibrate.
    Veitch RK; Sherratt HS; Bartlett K
    Biochem J; 1987 Sep; 246(3):775-8. PubMed ID: 3689331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction of dicarboxylic aciduria due to medium-chain triglyceride feeding from that due to abnormal fatty acid oxidation and fasting in children.
    Tserng KY; Griffin RL; Kerr DS
    Metabolism; 1996 Feb; 45(2):162-7. PubMed ID: 8596483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria.
    Holland PC; Sherratt HS
    Biochem J; 1973 Sep; 136(1):157-71. PubMed ID: 4772622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria.
    Tserng KY; Jin SJ; Kerr DS; Hoppel CL
    Metabolism; 1991 Jul; 40(7):676-82. PubMed ID: 1870421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Tserng KY; Jin SJ; Kerr DS; Hoppel CL
    J Lipid Res; 1990 May; 31(5):763-71. PubMed ID: 2380628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L; Pillay D; Alberti KG; Sherratt HS
    Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
    Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
    Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C6-C10-dicarboxylic aciduria: biochemical considerations in relation to diagnosis of beta-oxidation defects.
    Gregersen N; Kølvraa S; Mortensen PB; Rasmussen K
    Scand J Clin Lab Invest Suppl; 1982; 161():15-27. PubMed ID: 6959231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases.
    Suzuki Y; Shimozawa N; Yajima S; Yamaguchi S; Orii T; Hashimoto T
    Biochem Pharmacol; 1991 Feb; 41(3):453-6. PubMed ID: 1994902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatography--mass spectrometry (GC--MS) diagnosis of two cases of medium chain acyl-CoA dehydrogenase deficiency.
    Divry P; Vianey-Liaud C; Cotte J
    J Inherit Metab Dis; 1984; 7 Suppl 1():44-7. PubMed ID: 6434844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of rats against hypoglycin and pent-4-enoate toxicity by pretreatment with clofibrate [proceedings].
    Van Hoof F; Hue L; Sherratt HS
    Biochem Soc Trans; 1979 Feb; 7(1):163-5. PubMed ID: 437267
    [No Abstract]   [Full Text] [Related]  

  • 18. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
    Reddy JK; Hashimoto T
    Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peroxisomal beta-oxidation].
    Mannaerts GP; Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
    Koundakjian PP; Turnbull DM; Bone AJ; Rogers MP; Younan SI; Sherratt HS
    Biochem Pharmacol; 1984 Feb; 33(3):465-73. PubMed ID: 6231030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.